Trinity Biotech Price to Book Ratio 2010-2024 | TRIB
Historical price to book ratio values for Trinity Biotech (TRIB) over the last 10 years. The current price to book ratio for Trinity Biotech as of May 09, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Trinity Biotech Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-09 | 0.75 | 0.00 | |
| 2024-09-30 | 1.10 | 0.00 | |
| 2024-06-30 | 2.13 | $-2.91 | -0.73 |
| 2024-03-31 | 2.04 | 0.00 | |
| 2023-12-31 | 2.15 | 0.00 | |
| 2023-09-30 | 3.68 | 0.00 | |
| 2023-06-30 | 4.76 | 0.00 | |
| 2023-03-31 | 4.70 | 0.00 | |
| 2022-12-31 | 4.95 | $-0.26 | -18.76 |
| 2022-09-30 | 5.36 | 0.00 | |
| 2022-06-30 | 6.13 | $1.92 | 3.19 |
| 2022-03-31 | 5.30 | 0.00 | |
| 2021-12-31 | 7.15 | $-0.07 | -107.84 |
| 2021-09-30 | 10.80 | 0.00 | |
| 2021-06-30 | 14.70 | 0.00 | |
| 2021-03-31 | 18.80 | 0.00 | |
| 2020-12-31 | 19.05 | $-0.46 | -41.28 |
| 2020-09-30 | 10.10 | 0.00 | |
| 2020-06-30 | 10.90 | 0.00 | |
| 2020-03-31 | 5.50 | 0.00 | |
| 2019-12-31 | 5.17 | $0.98 | 5.27 |
| 2019-09-30 | 6.05 | 0.00 | |
| 2019-06-30 | 8.25 | 0.00 | |
| 2019-03-31 | 14.25 | 0.00 | |
| 2018-12-31 | 11.45 | $9.16 | 1.25 |
| 2018-09-30 | 20.00 | 0.00 | |
| 2018-06-30 | 25.00 | 0.00 | |
| 2018-03-31 | 25.75 | 0.00 | |
| 2017-12-31 | 25.50 | $13.56 | 1.88 |
| 2017-09-30 | 28.05 | 0.00 | |
| 2017-06-30 | 30.00 | 0.00 | |
| 2017-03-31 | 29.80 | 0.00 | |
| 2016-12-31 | 34.60 | $22.61 | 1.53 |
| 2016-09-30 | 66.10 | 0.00 | |
| 2016-06-30 | 56.70 | 0.00 | |
| 2016-03-31 | 58.30 | 0.00 | |
| 2015-12-31 | 58.80 | $44.64 | 1.32 |
| 2015-09-30 | 57.20 | 0.00 | |
| 2015-06-30 | 90.30 | 0.00 | |
| 2015-03-31 | 95.07 | 0.00 | |
| 2014-12-31 | 86.47 | $41.77 | 2.07 |
| 2014-09-30 | 90.23 | 0.00 | |
| 2014-06-30 | 113.73 | 0.00 | |
| 2014-03-31 | 118.55 | 0.00 | |
| 2013-12-31 | 123.00 | 0.00 | |
| 2013-09-30 | 106.46 | 0.00 | |
| 2013-06-30 | 82.44 | 0.00 | |
| 2013-03-31 | 81.62 | 0.00 | |
| 2012-12-31 | 69.72 | 0.00 | |
| 2012-09-30 | 60.78 | 0.00 | |
| 2012-06-30 | 58.02 | 0.00 | |
| 2012-03-31 | 50.90 | 0.00 | |
| 2011-12-31 | 48.56 | 0.00 | |
| 2011-09-30 | 43.70 | 0.00 | |
| 2011-06-30 | 47.42 | 0.00 | |
| 2011-03-31 | 42.96 | 0.00 | |
| 2010-12-31 | 40.35 | 0.00 | |
| 2010-09-30 | 28.99 | 0.00 | |
| 2010-06-30 | 27.85 | 0.00 | |
| 2010-03-31 | 24.96 | 0.00 | |
| 2009-12-31 | 18.50 | 0.00 | |
| 2009-09-30 | 18.09 | 0.00 | |
| 2009-06-30 | 20.24 | 0.00 | |
| 2009-03-31 | 7.97 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.014B | $0.057B |
| Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.816B | 27.87 |
| Boston Scientific (BSX) | United States | $152.176B | 38.10 |
| Stryker (SYK) | United States | $145.393B | 30.40 |
| EssilorLuxottica (ESLOY) | France | $127.544B | 0.00 |
| Medtronic (MDT) | Ireland | $107.067B | 15.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.941B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.439B | 27.54 |
| ResMed (RMD) | United States | $35.929B | 26.99 |
| GE HealthCare Technologies (GEHC) | United States | $31.992B | 15.19 |
| Agilent Technologies (A) | United States | $30.486B | 20.14 |
| Terumo (TRUMY) | Japan | $28.205B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.066B | 16.58 |
| Insulet (PODD) | United States | $21.859B | 85.82 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.837B | 12.10 |
| Baxter (BAX) | United States | $15.857B | 11.84 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.412B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.686B | 22.60 |
| Lantheus Holdings (LNTH) | United States | $5.598B | 14.27 |
| Prestige Consumer Healthcare (PBH) | United States | $4.325B | 19.27 |
| Perrigo (PRGO) | Ireland | $3.713B | 9.41 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.426B | 14.92 |
| ICU Medical (ICUI) | United States | $3.404B | 25.10 |
| Envista Holdings (NVST) | United States | $2.981B | 24.77 |
| QuidelOrtho (QDEL) | United States | $2.451B | 16.90 |
| GN Store Nord (GNNDY) | Denmark | $2.075B | 17.19 |
| LeMaitre Vascular (LMAT) | United States | $1.813B | 40.54 |
| AtriCure (ATRC) | United States | $1.534B | 0.00 |
| Neogen (NEOG) | United States | $1.296B | 16.58 |
| Green Thumb Industries (GTBIF) | United States | $1.173B | 26.38 |
| Kestra Medical Technologies (KMTS) | United States | $1.164B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.156B | 11.75 |
| BioLife Solutions (BLFS) | United States | $1.106B | 0.00 |
| InMode (INMD) | Israel | $1.005B | 9.20 |
| Phibro Animal Health (PAHC) | United States | $0.910B | 11.64 |
| Evolus (EOLS) | United States | $0.632B | 0.00 |
| CeriBell (CBLL) | United States | $0.575B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.557B | 0.00 |
| Owens & Minor (OMI) | United States | $0.542B | 4.49 |
| Valneva SE (VALN) | France | $0.541B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.504B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.431B | 0.00 |
| Surmodics (SRDX) | United States | $0.383B | 0.00 |
| Omeros (OMER) | United States | $0.360B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.358B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.290B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.288B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.283B | 10.42 |
| Aurora Cannabis (ACB) | Canada | $0.273B | 48.50 |
| Sanuwave Health (SNWV) | United States | $0.257B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.250B | 21.07 |
| Verano Holdings (VRNOF) | United States | $0.248B | 0.00 |
| Cerus (CERS) | United States | $0.247B | 0.00 |
| ZimVie (ZIMV) | United States | $0.244B | 11.09 |
| Canopy Growth (CGC) | Canada | $0.241B | 0.00 |
| Biote (BTMD) | United States | $0.219B | 6.15 |
| Quanterix (QTRX) | United States | $0.205B | 0.00 |
| High Tide (HITI) | Canada | $0.194B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.176B | 14.18 |
| Brainsway (BWAY) | Israel | $0.164B | 51.24 |
| TriSalus Life Sciences (TLSI) | United States | $0.162B | 0.00 |
| Organigram Global (OGI) | Canada | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.147B | 18.16 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.103B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| MacroGenics (MGNX) | United States | $0.090B | 0.00 |
| Agape ATP (ATPC) | $0.078B | 0.00 | |
| Fonar (FONR) | United States | $0.077B | 10.77 |
| Veru (VERU) | United States | $0.074B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.063B | 0.00 |
| United Health Products (UEEC) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| Apyx Medical (APYX) | United States | $0.044B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 56.00 |
| United-Guardian (UG) | United States | $0.037B | 12.79 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| Nephros (NEPH) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |